Skip to main content

Felicia Cao

Felicia Cao, MD, PhD, is a UNC Lineberger Comprehensive Cancer Center member with research interests in the improvement of cell therapies for the treatment of solid tumor malignancies and understanding the late effects of adoptive cell therapy.

MD, PhD
Assistant Professor, Hematology
UNC-Chapel Hill
Immunology and Immunotherapy Program

For patients: UNC Health profile

Area of Interest

My research focuses on adoptive cell therapy, particularly chimeric antigen receptor (CAR) T-cell therapy for treatment of hematological and solid tumor malignancies. My research interests are in the improvement of cell therapies for the treatment of solid tumor malignancies and understanding the late effects of adoptive cell therapy. I am particularly interested in characterizing immunity after CAR T-cell treatment, including immune reconstitution, delayed cytopenias, and infectious risk.

Find publications on PubMed

Awards and Honors

  • FDA – AACR Oncology Educational Fellowship Trainee, 2024-2025
  • Immunotherapy Training Grant (IM-TAG) T32, UNC-Chapel Hill, 2023-2025
  • Ruth L. Kirschstein National Research Service Award F30, National Cancer Institute, 2016-2018
  • Dean’s Award, Baylor College of Medicine, 2016
Headshot of Felicia Cao.